G

ood morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day and please do stay in touch …

A war of words has broken out between Gilead Sciences and Express Scripts. Last week, a Gilead exec insisted pharmacy benefit managers keep prices high. Now, an Express Scripts executive has sent a letter to the drug maker to complain that, “If you’re saying that the drug really is worth about $50,000, then it’s only right to make sure payers are made whole for overpaying,” according to Bloomberg News.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.